Eszopiclone filed in Japan for insomnia
This article was originally published in Scrip
Executive Summary
Eisai has submitted a marketing approval application in Japan for the insomnia product eszopiclone, in line with its earlier prediction of a filing by the end of its fiscal year next 31 March.